Content area

|

Single-port laparoscopic rectal surgery – a systematic review

Authors
Ida Lolle, Steffen Rosenstock & Orhan Bulut, Department of Gastroenterology, Surgical Unit, Hvidovre Hospital

Abstract

Introduction: Single-port laparoscopic surgery (SPLS) for colonic disease has been widely described, whereas data for SPLS rectal resection are sparse. This review aimed to evaluate the feasibility, safety and complication profile of SPLS for rectal diseases.

Methods: A systematic literature search of PubMed and Embase was performed in September 2013 according to the PRISMA guidelines. Original reports on the use of SPLS in high and low anterior resection, Hartmann’s operation and abdominoperineal resection were included. Outcome measures were intra-operative details and complications, short-term oncological outcome and early complication profile.

Results: No randomised studies or controlled clinical studies were identified. All studies were case series or case reports. Only five studies included more than ten patients operated with SPLS, comprising a total of 120 patients. These studies formed the basis for the final analyses of outcome. Operative times ranged from 79 to 280 min. Conversion rates to conventional laparoscopic surgery and to open surgery were 12% and 2.5%, respectively. The number of harvested lymph nodes in malignant cases was 13-18. The post-operative complication rate was 25.5%. Length of hospital stay was 1-16 days. No 30-day mortality was reported.

Conclusion: Short-term results suggest that SPLS for rectal disease is feasible and safe with an acceptable complication rate when performed by experienced surgeons in selected patients. Oncological safety and the possible benefits remain to be proven. Future rectal SPLS procedures should be performed in a protocolled set-up.

Funding: not relevant.

Trial registration: not relevant.

METHODS

Search strategy

A systematic search on published literature was done using the PRISMA guidelines [12, 13]. Studies were identified through searches of PubMed and Embase in September 2013. The search terms used were “single incision OR single site OR single port OR single access OR single trocar” AND “laparoscopic” – AND “colorectal surgery OR rectal surgery OR rectal resection OR anterior resection OR abdominoperineal resection”. The limitations were language English and species human. For Embase, the search was further limited to “articles” and for PubMed“ to case report, comparative study, clinical trial, controlled clinical trial, randomised controlled trial” as only original studies were considered. Citations from the included articles were searched, but revealed no more relevant articles. Two studies on rectal SPLS were published later than the systematic search [14, 15]. They were identified by a co-author and included.

Selection criteria

Articles were selected for detailed reading if the abstract contained data on patients operated with SPLS for benign or malignant rectal disease with high or low anterior resection (HAR/LAR), Hartmann’s operation (HO) or abdominoperineal resection (APR). Only original case reports, series or trials were considered. Reviews, comments and guidelines were excluded. Full text articles of relevant studies were retrieved for further selection. Data collected for this review were taken from the published reports. Authors were not contacted to obtain raw data. Only studies with extractable data on rectal SPLS procedures were included. Studies containing mixed series of colonic and rectal SPLS were included if data on rectal SPLS could be isolated and extracted. Hybrid techniques and NOTES procedures were excluded. All included studies had to report the indication for surgery and to contain data on intra-operative, oncological and post-operative outcome. To avoid duplication of data, data from the same unit or hospital were included only once, using the most recent publication. To reduce selection bias and data reporting bias inherent to case reports and very small series, only series of more than ten patients were included for the final analyses of SPLS outcomes.

Data collection and analyses

Two authors (IL and OB) reviewed the full text articles that met the inclusion criteria and extracted information on study population characteristics: age, body mass index (BMI) and previous abdominal surgery; indication for SPLS: benign or malignant disease; operative details and technical data: type of resection, type of SPLS port, operating time, per-operative complications, conversion to CLS or open surgery and length of incision; oncological data: preoperative neoadjuvant chemoradiotherapy (CRT), number of harvested lymph nodes (LNH), resection margins (CRM), completeness of the mesorectal fascia, American Joint Committee of Cancer (AJCC) stage and tumour size; and post-operative outcomes: post- operative complications, reoperation, length of stay (LOS) and 30-day mortality.

RESULTS

Included studies

The systematic literature search is illustrated by a PRISMA flow diagram (Figure 1). A total of 12 relevant articles comprising 145 patients were identified [14-25]. Only five studies met the inclusion criteria which reduced the number of eligible patients to 120 (Table 1) [14, 16-19].

Quality of included studies

No randomised studies or controlled clinical studies were found (Table 1). Only two comparative case series were identified [15, 17]. All other studies were either non-comparative case series [14, 16, 18, 19, 21, 22, 25] or case reports [20, 23, 24]. Most series included relatively few patients with a mixture of both colonic and rectal SPLS procedures as well as benign and malignant diseases. Two studies included cases treated with hybrid techniques [15, 23]. Of the five case series that reported more than ten cases of pure rectal SPLS [14, 16-19], only one study was comparative [17]. All others were non-comparative studies [14, 16-19]. Due to poor study quality, significant heterogeneity, risk of selection and publication bias, and lack of prospective randomised or controlled clinical studies, these data were not found to be suitable for a meta-analysis. The five studies shown in Table 1 constitute the basis for the review.

Study population characteristics and indications and procedures for rectal single-port laparoscopic surgery

Study population characteristics are summarised in Table 1. Indications for surgery included both malignant and benign rectal diseases. The majority of the reported indications were malignancies (74%). Diverticular disease was the most commonly reported benign indication (20%). Other benign indications were ulcerative colitis (2.5%) and polyps (< 1%). The three most frequently reported procedures were high anterior resection with or without a protective ileostomy (HAR-L/HAR): 62 out of a total of 120 procedures (52%); low anterior resection with or without a protective ileostomy (LAR-L/LAR): 27 procedures (22.5%); and abdominoperineal resection (APR): 28 procedures (23%) (Table 1). Even though surgeries were rectal procedures, they represented a heterogeneous group in terms of surgical complexity and expected post-operative outcome.

Ports and abdominal access

The most commonly used ports were SILS (Covidien), Triport (Advanced Surgical Concepts), Glove-Port-Single Port, Nelis Ltd. and GelPOINT (Applied Medical Corp) with access though the umbilicus or through a planned stoma site.

Conversion, operating times, and intra-operative outcomes

Placement of extra ports was considered conversion to CLS. All five studies specified whether conversion to open surgery had been done, and four studies gave information on conversion to CLS. In 12 out of 101 procedures (12%), conversion to CLS was done with one or more extra ports being introduced. In three out of 120 procedures (2.5%), conversion to open surgery was done. Intra-operative outcomes including conversion rates, operative time and per-operative bleeding are summarised in Table 2. Two studies measured incision length at the end of the procedure. Chew et al [16] reported a final incision length median of 5 cm/range 3-7 cm, and Sirikurnpiboon & Jivapaisarnpong reported a final incision length mean of 5.5 cm [18]. The remaining studies only reported the incision length needed for placement of the single port (2.5-3 cm).

Oncological outcome

A total of 89 cases of rectal SPLS for malignant disease were reported. Four studies specified the number of harvested lymph nodes (LNH) (median number 13-18). All four studies reported one or more cases with less than 12 LNH. Only one study specified whether the patients had received preoperative neoadjuvant CRT [14]. One study included only patients who had rejected preoperative neoadjuvant chemotherapy, not mentioning radiotherapy [18]. AJCC stage was reported in three studies. Bulut et al [14] included 13 (52%) stage I+II cases and 12 (48%) stage III+IV cases. Chew et al [16] reported two (20%) stage I cases, five (50%) stage II cases and three (30%) stage III cases. Sirikurnpiboon & Jivapaisarnpong [18] reported two (20%) stage II and eight (80%) stage III cases. In three studies that gave information on radicality, all resections were R0 [14, 17, 18] (Table 2). Tumour size, resection margins (CRM) and completeness of the mesorectal fascia were reported in the study by Bulut et al [14]. Median tumour size was 32 mm (range 0-82 mm), and median CRM was 10 mm (range 1-25 mm). The mesorectal fascia was deemed complete or nearly complete in 92% of the patients. Sirikurnpiboon & Jivapaisarnpong [18] reported a CRM of at least 2 mm in all cases (median CRM not specified). The mesorectal excision was deemed complete or nearly complete in all patients.

Post-operative complications and length of hospital stay

The post-operative complication profile was reported in details in three studies [14, 17, 18]. The overall complication rate was (23/90) 25.5%. Osborne et al [17] reported 11 post-operative complications in 55 patients. Two had anastomotic leakage and one small-bowel obstruction due to haematoma. Other complications comprised bleeding (n = 1), pulmonary embolus (n = 1) and urinary retention (n = 4). Median LOS was one day, and five patients were readmitted. The length of the follow-up period was not specified, but one incisional hernia was reported at long-term follow-up.

In the study by Bulut et al [14] which included 25 patients, seven complications were seen in six patients: anastomotic leakage (n = 1), compartment syndrome in calf due to lower limp arterial insufficiency (n = 1) and urinary tract infections (n = 2). Three patients were readmitted because of electrolyte and fluid derangement, aseptic pelvic fluid collection and secretion from a rectal stump. No late wound complications or incisional hernias were seen in the follow-up period (median 22 months).

Sirikurnpiboon & Jivapaisarnpong [18] reported six post-operative complications among the ten included patients: Lung atelectasis (n = 2), non-organic cause delirium (n = 2), thombophlebitis on the forearm (n = 1) and perineal wound infection (n = 1). No re-admissions were reported.

Chew et al [16] did not report the complication profile but mentioned two major complications, i.e. anastomotic leakage (n = 1) and post-operative bleeding which could be managed conservatively (n = 1).

Vestweber et al [19] did not specify data on post-operative complications, 30-day mortality or readmissions. The mean/median length of hospital stay (LOS) varied from 1-16 days with the longest LOS seen in patients undergoing APR. HAR was associated with the shortest LOS. Thirty-day mortality was reported in three studies [14, 16, 17]. There were no deaths reported among the 91 patients included in the analysis.

DISCUSSION

Reducing surgical trauma has been a key issue in all new emerging surgical techniques for the past two decades. Laparoscopic surgery undoubtedly represents the most important breakthrough in this context. Today, CLS for rectal cancer is offered at many institutions around the world. New surgical approaches such as SPLS are constantly being developed to further improve cosmetic outcomes and to reduce the surgical trauma. In rectal SPLS, intra-abdominal dissection and tissue manipulation are generally not much different from CLS, but SPLS differs from CLS by using only one incision. What is known at this point is that rectal SPLS is technically feasible and safe in selected groups of patients when surgery is performed by experienced laparoscopic surgeons. RCTs from other surgical fields have examined some of the potential benefits and harms of SPLS. A small RCT on colectomy found a lower pain score the first two days in SPLS versus CLS [26]. A recent RCT of SPLS versus CLS cholecystectomy [27] showed improved cosmetic rating, no increased rate of incisional hernia and no reduction in pain. Marks et al [28] found significantly increased hernia rates one year after SPLS cholecystectomies compared with CLS. Cosmesis scores favoured SPLS over CLS. Similar studies for rectal SPLS have not been made at this point, and the potential benefits remain to be proven.

The available evidence for SPLS is generally of poor scientific quality and stems from case reports, small case series and a single case-comparison study. Such studies are likely to suffer from inadequate reporting [29], significant bias in patient-selection, reporting bias and publication bias [30]. Several retrospective case-comparison studies of AR for sigmoid cancer and sigmoid resections [31-33] have been published over the past years. Like the rectal SPLS studies, they show that SPLS for left- sided colon lesions is feasible with short-term outcomes comparable to CLS. Detailed data on complications after rectal SPLS are limited, but available data suggest that complication rates and types of complications of rectal SPLS are comparable to what is reported for CLS in large RCTs [1, 3, 34].

SPLS cases may be converted into open surgery or into CLS by inserting one or more additional ports. In the latter case, the additional surgical trauma is minimal and hardly measureable. In this review, the conversion rate to open surgery was less than 3%, and additional ports were rarely necessary. This conversion rate is extremely low compared with similar rates reported in RCTs on rectal cancer [1, 3, 34], which probably reflects selection bias both in choice of patient and surgeon.

It is difficult to be conclusive about operative time for rectal SPLS compared with CLS at this point. The only comparative study [17] shows faster operative time for SPLS than for CLS, which is surprising and not really accounted for in the article. Depending on the procedure, the operative time varies from 79 to 280 minutes in the reviewed studies, which reflects the heterogeneity of operations. The shortest operating time was observed in a series of HAR, whereas the longest operating time was seen in a series of mixed LAR and APR. Currently, no long-term data on oncological outcomes of rectal SPLS are available. Short-term data imply that median LNH and resection margins after SPLS are acceptable. LNH, however, ranged from two to 34 lymph nodes. Obviously, two harvested lymph nodes may not be sufficient to ensure correct staging of the patient. The majority of papers on rectal SPLS did not specify if the patients had received neo-adjuvant CRT. It is well known that preoperative neoadjuvant CRT decreases LNH from proctectomy specimens [35]. Unfortunately, it is unknown if cases with few harvested lymph nodes had CRT. There has been much focus on the completeness of the mesorectal fascia after rectal resection. Muscularis propria resections are associated with poorer outcomes as completeness of the mesorectal fascia is often used as a proxy for the quality of surgery [36]. Only two studies reported these details [14, 18] as well as data on CRM, and they found that most specimens were intact and all had negative CRM. Such information is essential if the pro and cons of SPLS are to be established.

The reported median BMI ranges from 22 to 26.5 kg/m2, which suggests that patients were highly selected for SPLS. In the study by this author [14] which included only rectal cancer patients, the following parameters affected patient selection: Tumour distance from anal verge, size of tumour, and BMI together with the patient’s anatomical shape. Chew et al [16] considered BMI, tumour stage and previous abdominal surgery. It is unknown if the results of studies based on very selected populations can be generalised to all patient categories, i.e. if rectal SPLS will be as safe and feasible in patients with large tumours, narrow pelvises, high BMI, and in patients with previous abdominal surgery. Extraction and removal of large tumours will often require enlargement of the single port site, which may eliminate the benefits of a single, relatively small incision.

If SPLS has a place in cancer surgery in the future, long-term oncological outcome such as over-all and disease-free survival is by far the most important issue. Keeping in mind the limitations of the present data, they do not seem to indicate that SPLS may lead to a poorer oncological outcome and survival than CLS and open surgery. Large-scale randomised trials including unselected patients should compare CLS with rectal SPLS to establish overall feasibility and surgical and oncological safety. Long-term studies focusing on non-oncological outcomes such as hernias, adhesion-caused reoperations, quality of life and cosmesis are also needed to document any other clinically relevant advantages of SPLS compared to other methods. In that context, the possibly increased risk of parastomal and incisional hernias must be addressed specifically as it is unknown if the single port may be associated with higher risk of hernia formation, irrespective of whether it is used only as abdominal entry site or as a stoma site. It is recommended that future SPLS procedures are done in a protocolled set-up.

Correspondence: Ida Lolle, Gastroenheden, Kirurgisk Sektion, Hvidovre Hospital, Kettegård Allé 30, 2650 Hvidovre, Denmark. E-mail: ida.lolle.01@.regionh.dk.

Accepted: 14 May 2014

Conflicts of interest:Disclosure forms provided by the authors are available with the full text of this article at www.danmedj.dk

Bib ref: 
Dan Med J 2014;61(7):A4878
Magazine: 

REFERENCES

  1. Kang SB, Park JW, Jeong SY et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short term outcomes of an open-label randomized controlled trial. Lancet Oncol 2010;11:637-45.

  2. Green BL, Mashall HC, Collinson F et al. Long-term follow-up of the Medical Researc Council CLASICC trial of conventional versus laparoscopically assisted resection in colonic cancer. Br J Surg 2013;100:75-82.

  3. Van der Pas MH, Haglind E, Cuesta MA et al. Colorectal cancer Laparoscopic or Open Resection (II) (COLOR II) Study Group. Laparoscopic or open surgery for rectal cancer (COLOR II): short-term outcomes of a randomized, phase 3 trial. Lancet Oncol 2013;14:201-18.

  4. Schwenk W, Haase O, Neudecker J et al. Short term benefits for laparoscopic colorectal resection. Cochrane Database Syst Rev 2005;(3):CD003145.

  5. Trastulli S, Cirocchi R, Listorti C et al. Laparoscopic vs open resection for rectal cancer: a meta-analysis of randomized clinical trials. Colorectal Dis 2012;14:e277-e296.

  6. Bucher P, Pugin F, Morel P. Single port access laparoscopic right hemicolectomy. Int J Colorectal Dis 2008;23:1013-16.

  7. Remzi FH, Kirat JH, Geisler DP. Single-port laparoscopy in colorectal surgery. Colorectal Dis 2008;10:823-26.

  8. Levic K, Bulut O. The short term outcomes of conventional and single port laparoscopic surgery for rectal cancer: A comparative non-randomized study. Minim Invasive Ther Allied Technol. 3 February 2014 (epub ahead of print).

  9. Fung AK, Aly EH. Systematic review of single-incision laparoscopic colonic surgery. Br J Surg 2012;99:1353-64.

  10. Maggiori L, Gaujoux S, Tribillon E et al. Single-incision laparoscopy for colorectal resection: a systematic review and meta-analysis of more than a thousand procedures. Colorectal Dis 2012;14:e643-e654.

  11. Makino T, Milsom JW Lee SW. Feasibility and safety of single-incision laparoscopic colectomy. Ann Surg 2012;255:667-76.

  12. Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.

  13. Moher D, Liberati A, Tetzlaff J et al for the PRISMA group. Preferred reporting items for systematic reviews and meta-analyses. The PRISMA statement. BMJ 2009;339:b2535.

  14. Bulut O, Aslak K, Rosenstock S. Technique and short-term outcome of single-port surgery for rectal cancer: A feasibility study of 25 patients. Scand J Surg 2014;103:26-33.

  15. Sourrouille I, Dumont F, Goéré D et al. Resection of rectal cancer via an abdominal single-port access: short-term results and comparison with standard laparoscopy. Dis Colon Rectum 2013;56:1203-10.

  16. Chew MH, Wong MTC, Lim BYK et al. Evaluation of current devices in single incision laparoscopic surgery: a preliminary experience in 32 consecutive cases. World J Surg 2011;35:873-80.

  17. Osborne AJ, Lim J, Gash KJ et al. Comparison of single-incision laparoscopic high anteriorresection with standard laparoscopic high anterior resection. Colorectal dis 2013;15:329-33.

  18. Sirikurnpiboon S, Jivapaisarnpong P. Single-access laparoscopic rectal surgery is technically feasible. Minim Invasive Surg 2013;2013:687134.

  19. Vestweber B, Galetin T, Lammerting K et al. Single-incision laparoscopic surgery: outcomes from 224 colonic resections performed at a single center using SILS. Surg Endosc 2013;27:434-42.

  20. Bracale U, Nastro P, Bramante S et al. Single incision laparoscopic anterior resection for cancer using a “QuadiPort Access System”. Acta Chir Iugosl 2010;57:105-9.

  21. Law WL, Fan JKM, Poon JTC. Single-incision laparoscopic colectomy: early experience. Dis Colon Rectum 2010;53:284-8.

  22. Cianchi F, Qirici E, Trallori G et al. Single-incision laparoscopic colectomy: technical aspects and short-term results. Updates Surg 2012;64:19-23.

  23. Hamzaoglu I, Karahasanoglu T, Baca B et al. Single-port laparoscopic spincter-saving mesorectal excision for rectal cancer. Arch Surg 2011;146:75-81.

  24. Ragupathi M, Ramos-Valadez DI, Yaakovian MD et al. Single-incision laparoscopic colectomy: a novel approach through a Pfannenstiel incision. Tech Coloproctol 2011;15:61-5.

  25. Uematsu D, Akiyama G, Narita M et al. Single-access laproscopic low anterior resection with vertical suspension of the rectum. Dis Colon Rectum 2011;54;632-7.

  26. Poon JTC, Cheung CW, Fan JKM et al. Single-incision versus conventional laparoscopic colectomy for colonic neoplasm: a randomized, controlled trial. Surg Endosc 2012;26:2729-34.

  27. Jørgensen LN, Rosenberg J, Al-Tayer H et al. Randomized clinical trial of single- versus multi-incision laparoscopic cholecystectomy. Br J Surg 2014;101:347-55.

  28. Marks JM, Phillips MS, Tacchino R et al. Single-incision laparoscopic cholecystectomy is associated with improved cosmesis scoring at the cost of significantly higher hernia rates: 1-year results of a prospective randomized, multicenter single-blinded trial of traditional multiport laparoscopic cholecystectomy vs single-incision laparoscopic cholecystectomy. J Am Coll Surg 2013;216;1037-47.

  29. ichason TP, Paulson SM, Lowenstein SR et al. Case reports describing treatments in the emergency medicin literature: missing and misleading information. BMC Emerg Med 2009;9:10.

  30. Easterbrook PJ, Berlin JA, Gopalan R et al. Publication bias in clinical research. Lancet 1991;337:867-72.

  31. Ramos-Valadez DI, Ragupathi M, Nieto J et al. Single-incision versus conventional laparoscopic sigmoid colectomy: a case-matched series. Surg Endosc 2012;26:96-102.

  32. Kwag SJ, Kim JG, Oh ST et al. Single incision vs conventional laparoscopic anterior resection forsigmoid colon cancer: a case-mached study. Am J Surg 2913;206:320-5.

  33. Park SJ, Lee KY, Kang BM et al. Initial experience of single-port laparoscopic surgery for sigmoid colon cancer. Worls J Surg 2013;37:652-6.

  34. Guillou PJ, Quirke P, Thorpe H et al; MRC CLASICC trial group. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005; 365:1718-26.

  35. Amajoyi R, Lee Y, Recio PJ et al. Neoadjuvant therapy for rectal cancer decreases the number of lymph nodes harvested in operative specimens. Am J Surg 2013;205:289-92.

  36. Quirke P, Steele R, Monson J et al. MRC CR07/NCIC-CTG CO16 Trial Investigators; NCRI Colorectal Cancer Study Group. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 2009;373:821-8.

💬 0 Comments

Add new comment